Study of causes of flare-ups and death in bronchiectasis
Part of Lungs & breathing clinical trials.
This study looks at what factors are linked to flare-ups and serious outcomes in people with non–cystic fibrosis bronchiectasis. You may be followed because your lung scans and recent stability help researchers understand what predicts worsening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Be stable for at least 4 weeks (no recent flare-up symptoms and no need for extra antibiotics)
- Have bronchiectasis confirmed by a high-resolution CT (detailed chest CT scan)
- Do not have a history of cystic fibrosis
- Do not have immune-related conditions such as low antibody levels (hypogammaglobulinemia)
- Be able to give informed consent (you or your legal representative)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bronchiectasis (ongoing lung damage with mucus and infections) may happen by using your medical records and genetic information. It may help researchers find better ways to understand different bronchiectasis types and guide future treatments.
This study looks at the genes and health data of people with bronchiectasis to better understand the disease. It may help find new ways to treat or manage your condition.
This trial tests whether improving nutrition can help people recover better from a bronchiectasis flare-up. If you've been told you are undernourished, this study may help you get tailored nutrition support to feel better.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
This study looks at how different types of inflammation in your sputum (mucus you cough up) relate to your lung health over time. It aims to understand why some people with bronchiectasis do better than others, which may help improve future treatments.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
Hear when a new Bronchiectasis Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.